Nature Clinical Practice Oncology

4.3(top 5%)

impact factor

588(top 50%)

papers

24.5K(top 10%)

citations

84(top 10%)

h-index

4.8(top 5%)

impact factor

1.3K

all documents

25.4K

doc citations

146(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	DNA methylation and gene silencing in cancer	Nature Clinical Practice Oncology	2005	993
2	Lessons from phase III clinical trials on anti-VEGF therapy for cancer	Nature Clinical Practice Oncology	2006	968
3	Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer	Nature Clinical Practice Oncology	2006	858
4	Do stress-related psychosocial factors contribute to cancer incidence and survival?	Nature Clinical Practice Oncology	2008	786
5	Strategies for discovering novel cancer biomarkers through utilization of emerging technologies	Nature Clinical Practice Oncology	2008	663
6	Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy	Nature Clinical Practice Oncology	2006	634
7	Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress	Nature Clinical Practice Oncology	2007	437
8	REporting recommendations for tumor MARKer prognostic studies (REMARK)	Nature Clinical Practice Oncology	2005	389
9	Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer	Nature Clinical Practice Oncology	2005	381
10	The concurrent chemoradiation paradigm—general principles	Nature Clinical Practice Oncology	2007	353
11	Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma	Nature Clinical Practice Oncology	2009	345
12	Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy	Nature Clinical Practice Oncology	2008	326
13	Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?	Nature Clinical Practice Oncology	2006	318
14	Metastasis: a therapeutic target for cancer	Nature Clinical Practice Oncology	2008	300
15	Drug Insight: histone deacetylase inhibitors—development of the new targeted anticancer agent suberoylanilide hydroxamic acid	Nature Clinical Practice Oncology	2005	299
16	Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself	Nature Clinical Practice Oncology	2005	268
17	Mechanisms of Disease: inflammation and the origins of cancer	Nature Clinical Practice Oncology	2005	255
18	Strategies for the management of hepatocellular carcinoma	Nature Clinical Practice Oncology	2007	253
19	Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer	Nature Clinical Practice Oncology	2005	252
20	Management of nonmelanoma skin cancer in 2007	Nature Clinical Practice Oncology	2007	224
21	Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial	Nature Clinical Practice Oncology	2006	222
22	Human papillomavirus in cervical and head-and-neck cancer	Nature Clinical Practice Oncology	2008	219
23	Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?	Nature Clinical Practice Oncology	2008	218
24	Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer	Nature Clinical Practice Oncology	2007	217
25	The chemoradiation paradigm in head and neck cancer	Nature Clinical Practice Oncology	2007	194
26	What is the role of radiotherapy in bladder-preserving cancer therapy?	Nature Clinical Practice Oncology	2005	193
27	Angiogenic inhibitors: a new therapeutic strategy in oncology	Nature Clinical Practice Oncology	2005	186
28	Drug Insight: role of the androgen receptor in the development and progression of prostate cancer	Nature Clinical Practice Oncology	2007	185
29	Mechanisms of Disease: cancer stem cells—targeting the evil twin	Nature Clinical Practice Oncology	2008	185
30	The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens	Nature Clinical Practice Oncology	2006	182
31	Serrated adenoma of the colorectum and the DNA-methylator phenotype	Nature Clinical Practice Oncology	2005	178
32	Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification	Nature Clinical Practice Oncology	2007	175
33	Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures	Nature Clinical Practice Oncology	2007	171
34	Response criteria for glioma	Nature Clinical Practice Oncology	2008	171
35	CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS	Nature Clinical Practice Oncology	2008	164
36	Perspectives in the treatment of gastric cancer	Nature Clinical Practice Oncology	2005	159
37	Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms	Nature Clinical Practice Oncology	2006	159
38	Origins of breast cancer subtypes and therapeutic implications	Nature Clinical Practice Oncology	2007	155
39	The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2	Nature Clinical Practice Oncology	2008	153
40	Will focal therapy become a standard of care for men with localized prostate cancer?	Nature Clinical Practice Oncology	2007	148
41	Angiogenesis as a strategic target for ovarian cancer therapy	Nature Clinical Practice Oncology	2008	146
42	Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?	Nature Clinical Practice Oncology	2008	144
43	Cancer chemoprevention: scientific promise, clinical uncertainty	Nature Clinical Practice Oncology	2005	135
44	Mechanisms of Disease: inflammatory mediators and cancer prevention	Nature Clinical Practice Oncology	2005	134
45	Mechanisms of Disease: temozolomide and glioblastoma—look to the future	Nature Clinical Practice Oncology	2008	132
46	Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions	Nature Clinical Practice Oncology	2007	129
47	Technology Insight: identification of biomarkers with tissue microarray technology	Nature Clinical Practice Oncology	2004	128
48	Mechanisms of Disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis	Nature Clinical Practice Oncology	2006	128
49	Prognostic false-positivity of the sentinel node in melanoma	Nature Clinical Practice Oncology	2008	126
50	Surgery Insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer	Nature Clinical Practice Oncology	2007	124

Scientometrics

Overviews

Citing Bodies

Nature Clinical Practice Oncology

Top Articles